Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
- PMID: 31287024
- PMCID: PMC6613269
- DOI: 10.1186/s13287-019-1310-1
Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
Abstract
The liver, the largest organ with multiple synthetic and secretory functions in mammals, consists of hepatocytes, cholangiocytes, hepatic stellate cells (HSCs), sinusoidal endothelial cells, Kupffer cells (KCs), and immune cells, among others. Various causative factors, including viral infection, toxins, autoimmune defects, and genetic disorders, can impair liver function and result in chronic liver disease or acute liver failure. Mesenchymal stem cells (MSCs) from various tissues have emerged as a potential candidate for cell transplantation to promote liver regeneration. Adipose-derived MSCs (ADMSCs) with high multi-lineage potential and self-renewal capacity have attracted great attention as a promising means of liver regeneration. The abundance source and minimally invasive procedure required to obtain ADMSCs makes them superior to bone marrow-derived MSCs (BMMSCs). In this review, we comprehensively analyze landmark studies that address the isolation, proliferation, and hepatogenic differentiation of ADMSCs and summarize the therapeutic effects of ADMSCs in animal models of liver diseases. We also discuss key points related to improving the hepatic differentiation of ADMSCs via exposure of the cells to cytokines and growth factors (GFs), extracellular matrix (ECM), and various physical parameters in in vitro culture. The optimization of culturing methods and of the transplantation route will contribute to the further application of ADMSCs in liver regeneration and help improve the survival rate of patients with liver diseases. To this end, ADMSCs provide a potential strategy in the field of liver regeneration for treating acute or chronic liver injury, thus ensuring the availability of ADMSCs for research, trial, and clinical applications in various liver diseases in the future.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Porcine Adipose-Derived Mesenchymal Stem Cells Retain Their Stem Cell Characteristics and Cell Activities While Enhancing the Expression of Liver-Specific Genes after Acute Liver Failure.Int J Mol Sci. 2016 Jan 5;17(1):62. doi: 10.3390/ijms17010062. Int J Mol Sci. 2016. PMID: 26742034 Free PMC article.
-
Adipose derived mesenchymal stem cells efficiently rescue carbon tetrachloride-induced acute liver failure in mouse.ScientificWorldJournal. 2014;2014:103643. doi: 10.1155/2014/103643. Epub 2014 Jun 4. ScientificWorldJournal. 2014. PMID: 24999489 Free PMC article.
-
Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis.Cytotherapy. 2015 Aug;17(8):1052-65. doi: 10.1016/j.jcyt.2015.04.010. Cytotherapy. 2015. PMID: 26139545
-
Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.J Cell Mol Med. 2020 Jan;24(1):40-49. doi: 10.1111/jcmm.14788. Epub 2019 Nov 6. J Cell Mol Med. 2020. PMID: 31691463 Free PMC article. Review.
-
The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases.J Cell Mol Med. 2015 Mar;19(3):511-20. doi: 10.1111/jcmm.12482. Epub 2014 Dec 23. J Cell Mol Med. 2015. PMID: 25534251 Free PMC article. Review.
Cited by
-
Integrated Transcriptome and Metabolomics to Reveal the Mechanism of Adipose Mesenchymal Stem Cells in Treating Liver Fibrosis.Int J Mol Sci. 2023 Nov 8;24(22):16086. doi: 10.3390/ijms242216086. Int J Mol Sci. 2023. PMID: 38003277 Free PMC article.
-
'Fat chance': a review of adipose tissue engineering and its role in plastic and reconstructive surgery.Ann R Coll Surg Engl. 2021 Apr;103(4):245-249. doi: 10.1308/rcsann.2020.7031. Epub 2021 Mar 8. Ann R Coll Surg Engl. 2021. PMID: 33682428 Free PMC article. Review.
-
Clinical Application of Induced Hepatocyte-like Cells Produced from Mesenchymal Stromal Cells: A Literature Review.Cells. 2022 Jun 22;11(13):1998. doi: 10.3390/cells11131998. Cells. 2022. PMID: 35805080 Free PMC article. Review.
-
Gene Therapy Based on Mesenchymal Stem Cells Derived from Adipose Tissue for the Treatment of Obesity and Its Metabolic Complications.Int J Mol Sci. 2023 Apr 18;24(8):7468. doi: 10.3390/ijms24087468. Int J Mol Sci. 2023. PMID: 37108631 Free PMC article. Review.
-
Still 'dwelling in the possibility' - critical update on stem cell therapy for acute on chronic liver failure.World J Stem Cells. 2020 Oct 26;12(10):1124-1132. doi: 10.4252/wjsc.v12.i10.1124. World J Stem Cells. 2020. PMID: 33178396 Free PMC article. Review.
References
-
- Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, Mittal V, Kobayashi H, Shido K, Lyden D, Sato TN, Rabbany SY, Rafii S. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468(7321):310–315. doi: 10.1038/nature09493. - DOI - PMC - PubMed
-
- Dong Z, Wei H, Sun R, Tian Z. The roles of innate immune cells in liver injury and regeneration. Cell Mol Immunol. 2007;4(4):241–252. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical